2022/06/09
Medigen Vaccine Biologics reports positive results from 200-dose bag for mass vaccination of COVID-19 vaccines
2022/06/05
Medigen Vaccine Biologics Completed Enrollment for First-in-Human study of Next-generation COVID-19 Vaccine, and Published Animal Challenge Data in International Journal
2022/05/13
Additional Update on Clinical Development on Medigen's MVC-COV1901 in the COVID-19 Solidarity Trial Vaccines
2022/03/02
BlueWillow Biologics and Medigen Vaccine Biologics Announce Positive Results for Intranasal COVID-19 Booster Candidate in Pre-clinical Studies
2021/12/23
Clinical Development Updates on Medigen's MVC-COV1901 in COVID-19 Solidarity Trial Vaccines
2021/12/02
CEPI and MVC co-fund mix-and-match booster trial of COVID-19 vaccines
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree